These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 8633944)
1. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations. Ciçek S; Demirkiliç U; Kuralay E; Ozal E; Tatar H Ann Thorac Surg; 1996 May; 61(5):1372-6. PubMed ID: 8633944 [TBL] [Abstract][Full Text] [Related]
2. Postoperative use of aprotinin in cardiac operations: an alternative to its prophylactic use. Ciçek S; Demirkiliç U; Ozal E; Kuralay E; Bingol H; Tatar H; Ozturk OY J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1462-7. PubMed ID: 8975837 [TBL] [Abstract][Full Text] [Related]
3. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting. Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562 [TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [TBL] [Abstract][Full Text] [Related]
5. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. Alvarez JM; Jackson LR; Chatwin C; Smolich JJ J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294 [TBL] [Abstract][Full Text] [Related]
6. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial. Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082 [TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414 [TBL] [Abstract][Full Text] [Related]
8. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination? Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162 [TBL] [Abstract][Full Text] [Related]
9. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss. Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery. Tempe DK; Banerjee A; Virmani S; Mehta N; Panwar S; Tomar AS; Ghambeer DK; Nigam M J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):326-30. PubMed ID: 11426363 [TBL] [Abstract][Full Text] [Related]
11. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Lindvall G; Sartipy U; van der Linden J Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456 [TBL] [Abstract][Full Text] [Related]
12. Defining the role of aprotinin in heart transplantation. Prendergast TW; Furukawa S; Beyer AJ; Eisen HJ; McClurken JB; Jeevanandam V Ann Thorac Surg; 1996 Sep; 62(3):670-4. PubMed ID: 8783991 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery. Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082 [TBL] [Abstract][Full Text] [Related]
14. [Aprotinin (Antilysin Spofa)--its effect on decreasing hemorrhage in the postoperative period in hip arthroplasty]. Cvachovec K; Sechovská H; Berousek J; Popelka S; Hladíková M Acta Chir Orthop Traumatol Cech; 2001; 68(5):311-4. PubMed ID: 11759474 [TBL] [Abstract][Full Text] [Related]
15. Low-dose aprotinin in cardiac operations. Haddad R; Kesrouani C; Nasr W J Med Liban; 2000; 48(3):157-60. PubMed ID: 11268570 [TBL] [Abstract][Full Text] [Related]
16. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages]. Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785 [TBL] [Abstract][Full Text] [Related]
17. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass. Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892 [TBL] [Abstract][Full Text] [Related]
18. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540 [TBL] [Abstract][Full Text] [Related]
19. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery]. Yasim A; Aşik R; Atahan E Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701 [TBL] [Abstract][Full Text] [Related]